Novavax Says Shortages Delaying Full-Speed Production of COVID Vaccine

(Reuters) – Novavax Inc has pushed back the timeline for hitting its production target of 150 million COVID-19 vaccine doses

Read more

Sinopharm Needs Trial Results to Decide if COVID-19 Vaccine Needs Booster Shot: Executive

BEIJING (Reuters) – China National Pharmaceutical Group (Sinopharm) will need to assess results from overseas Phase III clinical trials to

Read more